Yingliang U. Li
Nanchang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
IFI44 Orchestrates an IL-10-Driven M2 Macrophage Program in Breast Cancer: An Immune Prognostic Signature.
Journal: Breast cancer (Dove Medical Press)
Published: November 16, 2025
The impact of m6A modified cargo conveyed by exosomes on the tumor microenvironment.
Journal: Discover oncology
Published: November 12, 2025
Therapeutic targeting of circTNK2 with nanoparticles restores tamoxifen sensitivity and enhances NK cell-mediated immunity in ER-positive breast cancer.
Journal: Cancer letters
Published: February 05, 2025
Comprehensive analysis of the expression level, prognostic value, and immune infiltration of cuproptosis-related genes in human breast cancer.
Journal: Medicine
Published: October 21, 2024
Innovative Dual mRNA-Lipid Nanoparticle Therapy Targeting CRHBP and CFHR3 for Enhanced Treatment of Hepatocellular Carcinoma.
Journal: International journal of nanomedicine
Published: September 26, 2024
Risk factors and prognosis of sentinel lymph node metastasis in breast-conserving breast cancer: A retrospective study based on the SEER database.
Journal: Medicine
Published: March 01, 2024
The Correlation of Mouse Double Minute 4 (MDM4) Polymorphisms (rs4245739, rs1563828, rs11801299, rs10900598, and rs1380576) with Cancer Susceptibility: A Meta-Analysis.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: March 29, 2022
LncRNA CASC15 promotes migration and invasion in prostate cancer via targeting miR-200a-3p.
Journal: European review for medical and pharmacological sciences
Published: July 25, 2020
LncRNA NEAT1 accelerates breast cancer progression through regulating miR-410-3p/ CCND1 axis.
Journal: Cancer biomarkers : section A of Disease markers
Published: July 18, 2020
Last Updated: 09/26/2026